Flow diversion aneurysm treatment: Key market research findings
- The Americas dominate the market geographically
- Increasing adoption of flow diversion aneurysm stenting among surgeons
- Key vendors – Balt Extrusion, Medtronic, MicroVention, and Stryker
Technavio’s market research analysts predict the global market for flow diversion aneurysm treatment to grow at a CAGR of almost 15% between 2016 and 2020. The rising demand for minimally invasive endovascular surgeries is the major driving force behind the high demand for flow diversion aneurysm treatment. Minimally invasive endovascular surgeries reduce the duration of hospital stay, allowing a patient to recover faster, which also translates into better utilization of healthcare resources at a lower cost. Furthermore, as these surgeries are performed with minute incisions in the body to treat blockages in arteries so that they do not leave any visible scars. During 2015, the market was dominated by the Americas. The market in Americas will flourish during the forecast period owing to factors such as an increase in the older adult population, rise in the number of intracranial aneurysm procedures, and the preference for flow diverters over endovascular coils and clipping.
The new industry research report from Technavio discusses in detail the key drivers and trends responsible for the growth of this market and its sub-segments.
“Currently, the market is witnessing a rise in the demand for intracranial stenting procedures. This trend is incited by the increase in cases of cerebral aneurysm worldwide. The use of stents gives better navigability in tortuous vessels for optimal cerebral circulation. The introduction of new intracranial devices with flow diverters is highly feasible with complete occlusion rates, and intraoperative neurophysiological monitoring systems help in continuous functional monitoring of patients undergoing large-caliber vessel EC-IC bypass surgery,” says Barath Palada, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
Flow diversion aneurysm stenting is one of the most widely accepted minimally invasive procedures for the treatment of intracranial aneurysm by surgeons, interventional cardiologists, radiologists, and neurologists. The growing acceptance of flow diverters by physicians worldwide is leading to the increased use of other endovascular stents. Many hospitals and healthcare centers across the world are recommending the procedure to people with carotid artery stenosis.
The key vendors in the market include Balt Extrusion, Medtronic, MicroVention, and Stryker. The market is expected to see the launch of products that are in investigational stage by the FDA. This may intensify competition among the vendors, as there will be more vendors with FDA-approved products in the market. However, the clinical results with PED and SILK have shown positive results. As a result, the focus on clinical investigation and investment in R&D for the development and approval of products will make this a competitive market during the forecast period.
A more detailed analysis is available in the Technavio report, Global Flow Diversion Aneurysm Treatment Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
